Primary open-angle glaucoma: Association with cholesterol 24s-hydroxylase (CYP46a1) gene polymorphism and plasma 24-hydroxycholesterol levels

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 12, 2009, Pages 5712-5717

  Fourgeux, Cynthia ^a   Martine, Lucy ^a   Björkhem, Ingemar ^b   Diczfalusy, Ulf ^b   Joffre, Corinne ^a   Acar, Niyazi ^a   Creuzot Garcher, Catherine ^c,d   Bron, Alain ^c,d   Bretillon, Lionel ^a  

^a CENTRE DES SCIENCES DU GOÛT ET DE L ALIMENTATION   (France)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c DIJON UNIVERSITY HOSPITAL   (France)

^d UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

24 HYDROXYCHOLESTEROL; CHOLESTEROL 24 HYDROXYLASE; CHOLESTEROL DERIVATIVE; OXYGENASE; UNCLASSIFIED DRUG; 24-HYDROXYCHOLESTEROL; CHOLESTEROL 24-HYDROXYLASE; STEROID MONOOXYGENASE;

ADULT; AGE; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; BRAIN WEIGHT; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; CYP46A1 GENE; DISEASE ASSOCIATION; FEMALE; GENDER; GENE; GENE FREQUENCY; GENETIC RISK; GENOTYPE; HUMAN; LIVER WEIGHT; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; CROSS-SECTIONAL STUDY; GENETICS; INTRON; ISOTOPE DILUTION ASSAY; MASS SPECTROMETRY; POLYMERASE CHAIN REACTION; RISK FACTOR;

AGED; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; GLAUCOMA, OPEN-ANGLE; HUMANS; HYDROXYCHOLESTEROLS; INTRONS; MALE; MASS SPECTROMETRY; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RADIOISOTOPE DILUTION TECHNIQUE; RISK FACTORS; STEROID HYDROXYLASES;

EID: 73349120617     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-3655     Document Type: Article

References (74)

1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262-267.
2. Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004;363:1711-1720.
3. Quigley HA. Glaucoma: macrocosm to microcosm: The Frieden-wald Lecture. Invest Ophthalmol Vis Sci. 2005;46:2663-2670.
4. Kwon YH, Fingert JH, Kuehn MH, Alward WL. Primary open-angle glaucoma. New Engl J Med. 2009;360:1113-1124.
5. Resch ZT, Fautsch MP. Glaucoma-associated myocilin: a better understanding but much more to learn. Exp Eye Res. 2009;88:704-712.
6. Wiggs JL. Genetic etiologies of glaucoma. Arch Ophthalmol. 2007; 125:30-37.
7. Stewart WC, Sine C, Sutherland S, Stewart JA. Total cholesterol and high-density lipoprotein levels as risk factors for increased intraocular pressure. Am J Ophthalmol. 1996;122:575-577.
8. McGwin G, McNeal S, Owsley C, Girkin C, Epstein D, Lee PP. Statins and other cholesterol-lowering medications and the presence of glaucoma. Arch Ophthalmol. 2004;122:822-826.
9. Song J, Deng PF, Stinnett SS, Epstein DL, Rao PV. Effects of cholesterol-lowering statins on the aqueous humor outflow pathway. Invest Ophthalmol Vis Sci. 2005;46:2424-2432.
10. De Castro DK, Punjabi OS, Bostrom AG, et al. Effect of statin drugs and aspirin on progression in open-angle glaucoma suspects using confocal scanning laser ophthalmoscopy. Clin Exp Ophthalmol. 2007;35:506-513.
11. Bretillon L, Diczfalusy U, Bjorkhem I, et al. Cholesterol-24S-hydrox-ylase (CYP46A1) is specifically expressed in neurons of the neural retina. Curr Eye Res. 2007;32:361-366.
12. Ramirez DM, Andersson S, Russell DW. Neuronal expression and subcellular localization of cholesterol 24-hydroxylase in the mouse brain. J Comp Neurol. 2008;507:1676-1693.
13. 18O2 techniques in vivo and in vitro. J Biol Chem. 1997;272:30178-30184.
14. Björkhem I, Lötjohann D, Diczfalusy U, Stahle L, Ahlborg G, Wahren J. Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J Lipid Res. 1998;39:1594-1600.
15. Lund EG, Guileyardo JM, Russell DW. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc Natl Acad Sci USA. 1999;96:7238-7243.
16. Lund EG, Xie C, Kotti T, Turley SD, Dietschy JM, Russell DW. Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover. J Biol Chem. 2003;278:22980-22988.
17. Lutjohann D, Breuer O, Ahlborg G, et al. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hy-droxycholesterol from the brain into the circulation. Proc Natl Acad Sci USA. 1996;93:9799-9804.
18. Bretillon L, Lütjohann D, Stahle L, et al. Plasma levels of 24S-hydroxycholesterol reflect the balance between cerebral produc-tion and hepatic metabolism and are inversely related to body surface. J Lipid Res. 2000;41:840-845.
19. Kolsch H, Lutjohann D, Tulke A, Bjorkhem I, Rao ML. The neuro-toxic effect of 24-hydroxycholesterol on SH-SY5Y human neuro-blastoma cells. Brain Res. 1999;818:171-175.
20. Lutjohann D, Papassotiropoulos A, Bjorkhem I, et al. Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. J Lipid Res. 2000;41:195-198.
21. Borroni B, Archetti S, Agosti C, et al. Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer Disease: from risk factors to disease modulators. Neurobiol Aging. 2004; 25:747-751.
22. Combarros O, Infante J, Llorca J, Berciano J. Genetic association of CYP46 and risk for Alzheimer's disease. Dement Geriatr Cogn Disord. 2004;18:257-260.
23. Johansson A, Katzov H, Zetterberg H, et al. Variants of CYP46A1 may interact with age and APOE to influence CSF Abeta42 levels in Alzheimer's disease. Hum Genet. 2004;114:581-587.
24. Kolsch H, Lutjohann D, Ludwig M, et al. Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease. Mol Psychiatry. 2002;7:899-902.
25. Papassotiropoulos A, Streffer JR, Tsolaki M, et al. Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism. Arch Neu-rol. 2003;60:29-35.
26. Wang B, Zhang C, Zheng W, et al. Association between a T/C polymorphism in intron 2 of cholesterol 24S-hydroxylase gene and Alzheimer's disease in Chinese. Neurosci Lett. 2004;369:104-107.
27. Helisalmi S, Vepsalainen S, Koivisto AM, et al. Association of CYP46 intron 2 polymorphism in Finnish Alzheimeŕs disease samples and a global scale summary. J Neurol Neurosurg Psychiatry. 2006;77:421-422.
28. Ma SL, Tang NL, Lam LC, Chiu HF. Polymorphisms of the cholesterol 24-hydroxylase (CYP46A1) gene and the risk of Alzheimer's disease in a Chinese population. Int Psychogeriatr. 2006;18:37-45.
29. Fernandez Del Pozo V, Alvarez Alvarez M, Fernandez Martinez M, et al. Polymorphism in the cholesterol 24S-hydroxylase gene (CYP46A1) associated with the APOEpsilon3 allele increases the risk of Alzheimer's disease and of mild cognitive impairment progressing to Alzheimer's disease. Dement Geriatr Cogn Disord. 2006;21:81-87.
30. Li Y, Chu LW, Chen YQ, et al. Intron 2 (T/C) CYP46 Polymorphism Is associated with Alzheimer's disease in Chinese patients. Dement Geriatr Cogn Disord. 2006;22:399-404.
31. Papassotiropoulos A, Wollmer MA, Tsolaki M, et al. A cluster of cholesterol-related genes confers susceptibility for Alzheimer's disease. J Clin Psychiatry. 2005;66:940-947.
32. Fu BY, Ma SL, Tang NL, et al. Cholesterol 24-hydroxylase (CYP46A1) polymorphisms are associated with faster cognitive deterioration in Chinese older persons: a two-year follow up study. Int J Geriatr Psychiatry. Published online February 11, 2009.
33. Vega GL, Weiner M, Kolsch H, et al. The effects of gender and CYP46 and apoE polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients treated with statins. Curr Alzheimer Res. 2004;1:71-77.
34. Tedde A, Rotondi M, Cellini E, et al. Lack of association between the CYP46 gene polymorphism and Italian late-onset sporadic Alzheimer's disease. Neurobiol Aging. 2006;27:771-773.
35. Ingelsson M, Jesneck J, Irizarry MC, Hyman BT, Rebeck GW. Lack of association of the cholesterol 24-hydroxylase (CYP46) intron 2 polymorphism with Alzheimer's disease. Neurosci Lett. 2004;367: 228-231.
36. Kabbara A, Payet N, Cottel D, Frigard B, Amouyel P, Lambert JC. Exclusion of CYP46 and APOM as candidate genes for Alzheimeŕs disease in a French population. Neurosci Lett. 2004;363:139-143.
37. Chalmers KA, Culpan D, Kehoe PG, Wilcock GK, Hughes A, Love S. APOE promoter, ACE1 and CYP46 polymorphisms and beta-amyloid in Alzheimer's disease. Neuroreport. 2004;15:95-98.
38. Desai P, DeKosky ST, Kamboh MI. Genetic variation in the cholesterol 24-hydroxylase (CYP46) gene and the risk of Alzheimeŕs disease. Neurosci Lett. 2002;328:9-12.
39. Juhasz A, Rimanoczy A, Boda K, et al. CYP46 T/C polymorphism is not associated with Alzheimeŕs dementia in a population from Hungary. Neurochem Res. 2005;30:943-948.
40. Hoddap E, Parrish R, Anderson D. Clinical Decisions in Glaucoma. Saint Louis, MO: Mosby Year Book; 1993:53.
41. Dekaban AS. Changes in brain weights during the span of human life: relation of brain weights to body heights and body weights. Ann Neurol. 1978;4:345-356.
42. Urata K, Kawasaki S, Matsunami H, et al. Calculation of child and adult standard liver volume for liver transplantation. Hepatology. 1995;21:1317-1321.
43. Wynne HA, Cope LH, Mutch E, Rawlins MD, Woodhouse KW, James OF. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology. 1989;9:297-301.
44. Bretillon L, Sidén A, Wahlund LO, et al. Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases. Neuro-sci Lett. 2000;293:87-90.
45. Libby RT, Gould DB, Anderson MG, John SW. Complex genetics of glaucoma susceptibility. Annu Rev Genomics Hum Genet. 2005; 6:15-44.
46. Lam CY, Fan BJ, Wang DY, et al. Association of apolipoprotein E polymorphisms with normal tension glaucoma in a Chinese population. J Glaucoma. 2006;15:218-222.
47. Tamura H, Kawakami H, Kanamoto T, et al. High frequency of open-angle glaucoma in Japanese patients with Alzheimeŕs disease. J Neurol Sci. 2006;246:79-83.
48. Fan BJ, Wang DY, Fan DS, et al. SNPs and interaction analyses of myocilin, optineurin, and apolipoprotein E in primary open angle glaucoma patients. Mol Vis. 2005;11:625-631.
49. Mabuchi F, Tang S, Ando D, et al. The apolipoprotein E gene polymorphism is associated with open angle glaucoma in the Japanese population. Mol Vis. 2005;11:609-612.
50. Ressiniotis T, Griffiths PG, Birch M, Keers SM, Chinnery PF. Apo-lipoprotein E promoter polymorphisms do not have a major influence on the risk of developing primary open angle glaucoma. Mol Vis. 2004;10:805-807.
51. Junemann A, Bleich S, Reulbach U, et al. Prospective case control study on genetic association of apolipoprotein epsilon2 with intraocular pressure. Br J Ophthalmol. 2004;88:581-582.
52. Lake S, Liverani E, Desai M, et al. Normal tension glaucoma is not associated with the common apolipoprotein E gene polymorphisms. Br J Ophthalmol. 2004;88:491-493.
53. Ressiniotis T, Griffiths PG, Birch M, Keers S, Chinnery PF. The role of apolipoprotein E gene polymorphisms in primary open-angle glaucoma. Arch Ophthalmol. 2004;122:258-261.
54. Tomarev SI, Wistow G, Raymond V, Dubois S, Malyukova I. Gene expression profile of the human trabecular meshwork: NEIBank sequence tag analysis. Invest Ophthalmol Vis Sci. 2003;44:2588- 2596.
55. Vickers JC, Craig JE, Stankovich J, et al. The apolipoprotein epsi-lon4 gene is associated with elevated risk of normal tension glaucoma. Mol Vis. 2002;8:389-393.
56. Copin B, Brezin AP, Valtot F, Dascotte JC, Bechetoille A, Garchon HJ. Apolipoprotein E-promoter single-nucleotide polymorphisms affect the phenotype of primary open-angle glaucoma and demonstrate interaction with the myocilin gene. Am J Hum Genet. 2002;70:1575-1581.
57. Yucel I, Akar Y, Yucel G, Ciftcioglu MA, Keles N, Aslan M. Effect of hypercholesterolemia on inducible nitric oxide synthase expression in a rat model of elevated intraocular pressure. Vision Res. 2005;45:1107-1114.
58. Wang F, Jia J. Polymorphisms of cholesterol metabolism genes CYP46 and ABCA1 and the risk of sporadic Alzheimeŕs disease in Chinese. Brain Res. 2007;1147:34-38.
59. Bayer AU, Ferrari F. Severe progression of glaucomatous optic neuropathy in patients with Alzheimeŕs disease. Eye. 2002;16: 209-212.
60. Bayer AU, Ferrari F, Erb C. High occurrence rate of glaucoma among patients with Alzheimeŕs disease. Eur Neurol. 2002;47: 165-168.
61. Karseras AG. Progressive glaucoma in patients with Alzheimeŕs disease. Eye. 2004;18:229.
62. Nesher R, Trick GL. The pattern electroretinogram in retinal and optic nerve disease: a quantitative comparison of the pattern of visual dysfunction. Doc Ophthalmol. 1991;77:225-235
63. Parisi V. Correlation between morphological and functional retinal impairment in patients affected by ocular hypertension, glaucoma, demyelinating optic neuritis and Alzheimer's disease. Semin Ophthalmol. 2003;18:50-57.
64. Janciauskiene S, Krakau T. Alzheimeŕs peptide: a possible link between glaucoma, exfoliation syndrome and Alzheimeŕs disease. Acta Ophthalmol Scand. 2001;79:328-329
65. Ning A, Cui J, To E, Ashe KH, Matsubara J. Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease. Invest Ophthalmol Vis Sci. 2008;49:5136-5143
66. Brown J, Theisler C, Silberman S, et al. Differential expression of cholesterol hydroxylases in Alzheimeŕs disease. J Biol Chem. 2004;279:34674-34681.
67. Bjorkhem I, Andersson U, Ellis E, et al. From brain to bile: evidence that conjugation and omega-hydroxylation are important for elimination of 24S-hydroxycholesterol (cerebrosterol) in humans. J Biol Chem. 2001;276:37004-37010.
68. Ikeda H, Ueda M, Ikeda M, Kobayashi H, Honda Y. Oxysterol 7alpha-hydroxylase (CYP39A1) in the ciliary nonpigmented epithelium of bovine eye. Lab Invest. 2003;83:349-355
69. Moreira EF, Jaworski C, Li A, Rodriguez IR. Molecular and biochemical characterization of a novel oxysterol-binding protein (OSBP2) highly expressed in retina. J Biol Chem. 2001;276: 18570-18578.
70. Gordiyenko N, Campos M, Lee JW, Fariss RN, Sztein J, Rodriguez IR. RPE cells internalize low-density lipoprotein (LDL) and oxidized LDL (oxLDL) in large quantities in vitro and in vivo. Invest Ophthalmol Vis Sci. 2004;45:2822-2829
71. Li CM, Chung BH, Presley JB, et al. Lipoprotein-like particles and cholesteryl esters in human Bruch's membrane: initial characterization. Invest Ophthalmol Vis Sci. 2005;46:2576-2586.
72. Li CM, Presley JB, Zhang X, et al. Retina expresses microsomal triglyceride transfer protein: implications for age-related macu-lopathy.JLipid Res. 2005;46:628-640.
73. Tserentsoodol N, Sztein J, Campos M, et al. Uptake of cholesterol by the retina occurs primarily via a low density lipoprotein receptor-mediated process. Mol Vision. 2006;12:1306-1318.
74. /-mice exhibit reduced electroretinographic response and cholesteryl esters deposits in the retina. Invest Ophthalmol Vis Sci. 2008;49: 1307-1314.